OverviewSuggest Edit

ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. It offers a range of bispecific antibody platforms.

Latest Updates

Employees (est.) (Oct 2020)25
Cybersecurity ratingDMore

ABL Bio Financials and Metrics

Summary Metrics

Founding Date


ABL Bio total Funding

$90.8 m

ABL Bio latest funding size

$65 m

Time since last funding

2 years ago

ABL Bio investors

ABL Bio's latest funding round in June 2018 was reported to be $65 m. In total, ABL Bio has raised $90.8 m
Show all financial metrics

ABL Bio Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

ABL Bio Online and Social Media Presence

Embed Graph

ABL Bio Frequently Asked Questions

  • When was ABL Bio founded?

    ABL Bio was founded in 2016.

  • How many employees does ABL Bio have?

    ABL Bio has 25 employees.

  • Who are ABL Bio competitors?

    Competitors of ABL Bio include Precision Medicines, ASLAN Pharmaceuticals and NOXXON Pharma.